BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 10595625)

  • 1. The VITA project: prothrombin G20210A mutation and venous thromboembolism in the general population.
    Tosetto A; Missiaglia E; Frezzato M; Rodeghiero F
    Thromb Haemost; 1999 Nov; 82(5):1395-8. PubMed ID: 10595625
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
    Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
    Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypic APC resistance in carriers of the A20210 prothrombin mutation is associated with an increased risk of venous thrombosis.
    Castaman G; Tosetto A; Simioni M; Ruggeri M; Madeo D; Rodeghiero F
    Thromb Haemost; 2001 Sep; 86(3):804-8. PubMed ID: 11583311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Type and location of venous thromboembolism in carriers of Factor V Leiden or prothrombin G20210A mutation versus patients with no mutation.
    Kovac M; Mitic G; Mikovic Z; Antonijevic N; Djordjevic V; Mikovic D; Mandic V; Rakicevic L; Radojkovic D
    Clin Appl Thromb Hemost; 2010 Feb; 16(1):66-70. PubMed ID: 18796457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium.
    Martinelli I; De Stefano V; Taioli E; Paciaroni K; Rossi E; Mannucci PM
    Thromb Haemost; 2002 May; 87(5):791-5. PubMed ID: 12038778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
    Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
    Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C677T substitution in the methylenetetrahydrofolate reductase gene as a risk factor for venous thrombosis and arterial disease in selected patients.
    Gemmati D; Serino ML; Trivellato C; Fiorini S; Scapoli GL
    Haematologica; 1999 Sep; 84(9):824-8. PubMed ID: 10477457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different circumstances of the first venous thromboembolism among younger or older heterozygous carriers of the G20210A polymorphism in the prothrombin gene.
    De Stefano V; Rossi E; Paciaroni K; D'Orazio A; Cina G; Marchitelli E; Pepe R; Leone G
    Haematologica; 2003 Jan; 88(1):61-6. PubMed ID: 12551828
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of random allocation to vitamin E supplementation on the occurrence of venous thromboembolism: report from the Women's Health Study.
    Glynn RJ; Ridker PM; Goldhaber SZ; Zee RY; Buring JE
    Circulation; 2007 Sep; 116(13):1497-503. PubMed ID: 17846285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor V Leiden (G1691A) and prothrombin gene G20210A mutations as potential risk factors for venous thromboembolism after total hip or total knee replacement surgery.
    Wåhlander K; Larson G; Lindahl TL; Andersson C; Frison L; Gustafsson D; Bylock A; Eriksson BI
    Thromb Haemost; 2002 Apr; 87(4):580-5. PubMed ID: 12008938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The risk of recurrent venous thromboembolism in carriers and non-carriers of the G1691A allele in the coagulation factor V gene and the G20210A allele in the prothrombin gene. DURAC Trial Study Group. Duration of Anticoagulation.
    Lindmarker P; Schulman S; Sten-Linder M; Wiman B; Egberg N; Johnsson H
    Thromb Haemost; 1999 May; 81(5):684-9. PubMed ID: 10365737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The PORtromb Project: prothrombin G20210A mutation and venous thromboembolism in young people.
    Mansilha A; Araújo F; Sampaio S; Cunha Ribeiro LM; Braga A
    Cardiovasc Surg; 2002 Feb; 10(1):45-8. PubMed ID: 11790575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of 20210 A allele of the prothrombin gene in venous thromboembolism patients.
    Leroyer C; Mercier B; Oger E; Chenu E; Abgrall JF; Férec C; Mottier D
    Thromb Haemost; 1998 Jul; 80(1):49-51. PubMed ID: 9684784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coagulation factor II activity determination is not useful as a screening tool for the G20210A prothrombin gene allele.
    Gruenewald M; Germowitz A; Beneke H; Guethner C; Griesshammer M
    Thromb Haemost; 2000 Jul; 84(1):141-2. PubMed ID: 10928488
    [No Abstract]   [Full Text] [Related]  

  • 15. The prothrombin G20210A mutation is a risk factor for sudden hearing loss in young patients.
    Patscheke JH; Arndt J; Dietz K; Zenner HP; Reuner KH
    Thromb Haemost; 2001 Oct; 86(4):1118-9. PubMed ID: 11686335
    [No Abstract]   [Full Text] [Related]  

  • 16. Prothrombotic mutations, hormone therapy, and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration.
    Straczek C; Oger E; Yon de Jonage-Canonico MB; Plu-Bureau G; Conard J; Meyer G; Alhenc-Gelas M; Lévesque H; Trillot N; Barrellier MT; Wahl D; Emmerich J; Scarabin PY;
    Circulation; 2005 Nov; 112(22):3495-500. PubMed ID: 16301339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homozygous G20210A transition in the prothrombin gene associated with severe venous thrombotic disease: two cases in a French family.
    Zawadzki C; Gaveriaux V; Trillot N; Bauters A; Watel A; Alhenc-Gelas M; Preudhomme C; Jude B
    Thromb Haemost; 1998 Dec; 80(6):1027-8. PubMed ID: 9869179
    [No Abstract]   [Full Text] [Related]  

  • 18. G20210A prothrombin gene variant and clinical outcome in patients with a first acute coronary syndrome.
    Burzotta F; Leone AM; Paciaroni K; De Stefano V; Rossi E; Testa L; Giannico F; Leone G; Maseri A; Crea F; Andreotti F
    Haematologica; 2004 Sep; 89(9):1134-8. PubMed ID: 15377476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factor V Leiden and prothrombin gene G20210A mutation in children with venous thromboembolism.
    Bonduel M; Hepner M; Sciuccati G; Pieroni G; Feliú-Torres A; Mardaraz C; Frontroth JP
    Thromb Haemost; 2002 Jun; 87(6):972-7. PubMed ID: 12083504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between hyperhomocysteinemia and inherited thrombophilic factors in venous thromboembolism.
    De Stefano V; Casorelli I; Rossi E; Zappacosta B; Leone G
    Semin Thromb Hemost; 2000; 26(3):305-11. PubMed ID: 11011848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.